Texas Children's Hospital: Congenital Heart Disease Care Custom Case Solution & Analysis

Evidence Brief: Texas Childrens Hospital Congenital Heart Disease Care

Financial Metrics

• Volume: The Heart Center manages over 18000 clinic visits and performs between 800 and 900 cardiac surgeries annually.
• Cost Distribution: Time Driven Activity Based Costing (TDABC) analysis reveals that 10 percent of patients account for approximately 50 percent of total costs in the Congenital Heart Surgery unit.
• Cost Variation: Significant cost differences exist for identical procedures like the Tetralogy of Fallot repair, driven primarily by variations in clinical supplies and length of stay in the Cardiac Intensive Care Unit.
• Revenue Mix: A substantial portion of the patient base relies on Medicaid, which typically reimburses at rates lower than the actual cost of care, necessitating high operational efficiency.

Operational Facts

• Organizational Structure: The Heart Center operates as an Integrated Practice Unit (IPU), where all specialists—surgeons, cardiologists, and intensivists—are co-located and report to a single leadership structure.
• Personnel: The department employs over 1000 staff members dedicated specifically to pediatric heart care.
• Facility: Operations are centered in the Lester and Sue Smith Legacy Tower, a facility designed to support the IPU model with dedicated cardiac operating rooms and intensive care beds.
• Process Methodology: The hospital utilizes TDABC to map every step of the patient journey, measuring the time spent by each staff member and the capacity cost rate of all resources involved.

Stakeholder Positions

• Dr. Charles Fraser: Surgeon in Chief who advocates for data driven clinical decisions and the elimination of unnecessary variation in surgical protocols.
• Mark Wallace: Chief Executive Officer focused on the long term financial viability of the hospital through the transition from volume to value based care.
• Dr. Lara Shekerdemian: Chief of Critical Care who emphasizes the importance of multidisciplinary collaboration in the intensive care unit to reduce recovery times.
• Clinical Staff: Generally supportive of quality initiatives but wary of administrative burden and perceived threats to clinical autonomy.

Information Gaps

• Payer Contracts: Specific details regarding the percentage of revenue tied to value based or bundled payment contracts are not provided.
• Competitor Cost Profiles: Comparative TDABC data from peer institutions like Boston Childrens or Childrens Hospital of Philadelphia is absent.
• Long Term Outcomes: While short term surgical success is documented, the case lacks comprehensive data on the 10 year cost of care for chronic CHD patients.

Strategic Analysis

Core Strategic Question

• How can Texas Childrens Hospital utilize its granular cost data to lead the transition to value based reimbursement without eroding its clinical reputation or financial margins?
• How should the organization address clinical variation among high performing surgeons to further reduce the cost of care?

Structural Analysis

Strategic Options

• Option 1: Aggressive Clinical Standardization. Use TDABC data to mandate standardized care pathways for the top five most common CHD procedures.
  • Rationale: Eliminates high cost outliers and reduces supply waste.
  • Trade-offs: Potential friction with senior surgeons who value individual technique; risk of ignoring patient specific nuances.
  • Resources: Requires dedicated data analysts to provide real time feedback to surgical teams.
• Option 2: Direct to Employer Bundled Payments. Market fixed price bundles for specific CHD surgeries to large national employers and insurers.
  • Rationale: Captures market share by providing price certainty and leveraging superior outcome data.
  • Trade-offs: TCH assumes all financial risk for complications or extended stays.
  • Resources: Requires a sophisticated legal and contracting department to manage risk sharing agreements.

Preliminary Recommendation

Implementation Roadmap

Critical Path

• Month 1-2: Finalize standardized clinical pathways for the three highest volume procedures based on TDABC cost-to-outcome correlations.
• Month 3-4: Develop a risk adjustment model that accounts for patient complexity to ensure bundled prices remain fair and sustainable.
• Month 5-6: Initiate pilot negotiations with one major private insurer for a bundled payment trial.
• Month 7-12: Expand the TDABC and IPU model to the pediatric neurology department to replicate cardiac successes.

Key Constraints

• Physician Culture: The transition from individual autonomy to protocol adherence is the primary hurdle. Success depends on Dr. Fraser framing standardization as a tool for excellence rather than a cost cutting measure.
• Data Integration: Current electronic health records and accounting systems are often disconnected. Manual data extraction for TDABC is not scalable.

Risk-Adjusted Implementation Strategy

Executive Review and BLUF

BLUF

Dangerous Assumption

Unaddressed Risks

• Risk 1: Talent Attrition. Top tier surgeons often choose TCH for the freedom to innovate. Excessive standardization may lead to the loss of key personnel to institutions with less rigid protocols. (Probability: Medium; Consequence: High)
• Risk 2: Adverse Selection. If TCH becomes known for fixed price bundles, lower quality hospitals may refer their most complex, high cost patients to TCH, potentially overwhelming the risk adjustment models. (Probability: High; Consequence: Medium)

Unconsidered Alternative